Researchers with the University of North Carolina at Chapel Hill are looking into a new treatment for COVID-19. Vice chair of the study, Dr. David Wohl, professor of medicine in the division of infectious diseases, says the monoclonal antibody cocktail is able to attach to the virus and prevent it from hurting people.